33,461 followers
New Research: Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer: Background A recent phase III clinical trial (NCT03981796) evaluated the efficacy and safety of… #immunology http